Clinical Development

Line Extensions

Other potential clinical applications for VAS203

There are several iNOS mediated inflammatory conditions in the CNS that result in death or long-term disability. vasopharm is exploring with academic institutions in pre-clinical models which additional conditions might be most susceptible to treatment with VAS203.

We are further evaluating CNS diseases characterized by chronic neuroinflammation and neurodegeneration associated with iNOS activation.